[18], [19] VPA has also been demonstrated to have neuroprotective properties on glutamate-induced excitotoxicity via up-regulation of alpha-synuclein and increases neurite outgrowth in vitro
Interestingly, the benefit of liraglutide for tau phosphorylation in diabetic mice cannot be replicated by insulin treatment, suggesting that the unique neuroprotective effects of GLP-1RAs are medicated by pathways other than insulin signaling pathways [62]
For leaky gut syndrome (increased intestinal permeability), BPC-157's ability to enhance tight junction function and promote epithelial cell regeneration suggests therapeutic potential
Even the 4mg dose saw 61% and 44% losing 15 and 20% body weight respectively
You found this not helpful 0 of 0 found this helpful Berry Blast Show More + Show Less - Robert J First time using this product in my program
9-11 These clinical trials have demonstrated that GLP-1 RAs will provide similar, and sometimes superior, reductions in A1C compared to rapid-acting insulin